Stock Analysis on Net

Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data

Medtronic PLC, common-size consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

Microsoft Excel
Jan 26, 2024 Oct 27, 2023 Jul 28, 2023 Apr 28, 2023 Jan 27, 2023 Oct 28, 2022 Jul 29, 2022 Apr 29, 2022 Jan 28, 2022 Oct 29, 2021 Jul 30, 2021 Apr 30, 2021 Jan 29, 2021 Oct 30, 2020 Jul 31, 2020 Apr 24, 2020 Jan 24, 2020 Oct 25, 2019 Jul 26, 2019 Apr 26, 2019 Jan 25, 2019 Oct 26, 2018 Jul 27, 2018 Apr 27, 2018 Jan 26, 2018 Oct 27, 2017 Jul 28, 2017
Current debt obligations 1.13 1.49 0.57 0.02 6.29 6.29 6.37 4.11 0.94 0.02 0.01 0.01 3.93 4.21 6.20 3.06 0.91 0.96 1.60 0.93 1.53 1.52 1.72 2.25 3.03 3.31 8.04
Accounts payable 2.19 2.41 2.47 2.93 2.35 2.36 2.42 2.50 2.16 2.09 2.03 2.26 1.87 1.98 1.83 2.20 2.10 2.16 2.09 2.18 1.92 1.98 1.99 1.78 1.89 1.82 1.75
Accrued compensation 2.39 1.95 1.87 2.14 2.13 1.85 1.97 2.33 2.34 2.11 2.07 2.67 2.57 2.22 1.93 2.31 2.06 1.95 1.65 2.44 2.02 1.89 1.53 2.18 1.72 1.59 1.30
Accrued income taxes 1.22 1.21 1.12 0.92 0.70 0.70 0.61 0.77 0.42 0.51 0.37 0.47 0.41 0.42 0.42 0.55 0.49 0.49 0.55 0.63 0.73 0.61 0.87 1.07 0.97 0.92 0.72
Other accrued expenses 3.84 3.66 3.94 3.94 3.86 4.32 4.25 3.90 3.86 3.78 3.98 3.73 4.11 3.74 3.55 3.30 3.86 3.42 3.45 3.26 3.77 3.61 4.04 3.75 3.81 3.47 3.24
Current liabilities held for sale 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.06
Current liabilities 10.78% 10.72% 9.97% 9.95% 15.32% 15.51% 15.62% 13.62% 9.72% 8.50% 8.46% 9.14% 12.89% 12.59% 13.94% 11.43% 9.41% 8.97% 9.33% 9.45% 9.98% 9.60% 10.16% 11.03% 11.41% 11.11% 15.11%
Long-term debt 26.59 26.35 26.95 26.77 23.59 22.26 19.44 22.39 26.46 27.91 28.28 28.34 27.25 27.08 24.35 24.28 26.64 27.18 27.18 27.30 26.68 26.86 26.39 25.93 27.05 27.46 25.89
Accrued compensation and retirement benefits 1.15 1.13 1.20 1.20 1.17 1.12 1.23 1.22 1.49 1.64 1.66 1.67 2.10 2.11 2.09 2.11 1.72 1.73 1.80 1.84 1.48 1.48 1.57 1.56 1.59 1.56 1.66
Accrued income taxes 2.00 1.97 2.65 2.59 2.45 2.80 2.34 2.29 2.30 2.30 2.46 2.42 2.33 2.68 2.90 2.96 2.95 2.97 3.15 3.16 3.24 3.35 3.39 3.34 4.97 2.32 2.16
Deferred tax liabilities 0.68 0.76 0.76 0.78 0.79 0.93 1.00 0.97 1.05 1.12 1.15 1.10 1.27 1.30 1.31 1.29 1.38 1.51 1.47 1.42 1.53 1.50 1.50 1.56 1.42 1.95 2.60
Other liabilities 1.55 1.73 1.89 1.90 1.84 1.54 1.60 1.55 1.55 1.69 1.72 1.89 1.82 1.76 1.70 1.83 1.92 1.93 1.74 0.84 0.81 0.82 0.89 0.97 1.01 0.99 1.02
Noncurrent liabilities held for sale 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.89
Noncurrent liabilities 31.98% 31.95% 33.45% 33.24% 29.84% 28.66% 25.60% 28.43% 32.86% 34.65% 35.26% 35.42% 34.76% 34.94% 32.35% 32.47% 34.62% 35.32% 35.34% 34.57% 33.74% 34.00% 33.75% 33.36% 36.04% 34.28% 34.23%
Total liabilities 42.76% 42.67% 43.41% 43.19% 45.17% 44.17% 41.23% 42.05% 42.58% 43.15% 43.72% 44.56% 47.64% 47.53% 46.28% 43.90% 44.03% 44.30% 44.67% 44.02% 43.72% 43.60% 43.90% 44.39% 47.45% 45.40% 49.34%
Ordinary shares, par value $0.0001 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Additional paid-in capital 27.07 27.28 27.09 27.04 26.04 26.21 27.06 27.00 28.12 28.40 28.52 28.27 27.41 27.62 27.97 28.85 28.17 28.74 29.00 29.58 29.89 30.68 31.00 30.78 29.43 29.74 28.48
Retained earnings 33.75 33.59 33.34 33.42 31.99 31.96 33.67 33.25 32.25 31.58 31.06 30.72 28.80 28.71 29.62 31.02 30.39 29.67 28.90 29.29 29.04 28.55 27.56 26.67 24.45 26.93 23.98
Accumulated other comprehensive loss -3.81 -3.75 -4.05 -3.85 -3.39 -2.53 -2.16 -2.49 -3.14 -3.32 -3.50 -3.74 -4.03 -4.01 -4.03 -3.93 -2.74 -2.87 -2.72 -3.02 -2.77 -2.96 -2.59 -1.95 -1.44 -2.18 -1.92
Shareholders’ equity 57.02% 57.12% 56.38% 56.61% 54.65% 55.64% 58.58% 57.76% 57.23% 56.66% 56.08% 55.25% 52.18% 52.32% 53.56% 55.95% 55.81% 55.55% 55.18% 55.85% 56.16% 56.28% 55.98% 55.50% 52.44% 54.49% 50.55%
Noncontrolling interests 0.22 0.21 0.21 0.20 0.19 0.19 0.19 0.19 0.19 0.18 0.19 0.19 0.17 0.16 0.16 0.15 0.16 0.15 0.15 0.13 0.13 0.12 0.12 0.11 0.11 0.12 0.11
Total equity 57.24% 57.33% 56.59% 56.81% 54.83% 55.83% 58.77% 57.95% 57.42% 56.85% 56.28% 55.44% 52.36% 52.47% 53.72% 56.10% 55.97% 55.70% 55.33% 55.98% 56.28% 56.40% 56.10% 55.61% 52.55% 54.60% 50.66%
Total liabilities and equity 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%

Based on: 10-Q (reporting date: 2024-01-26), 10-Q (reporting date: 2023-10-27), 10-Q (reporting date: 2023-07-28), 10-K (reporting date: 2023-04-28), 10-Q (reporting date: 2023-01-27), 10-Q (reporting date: 2022-10-28), 10-Q (reporting date: 2022-07-29), 10-K (reporting date: 2022-04-29), 10-Q (reporting date: 2022-01-28), 10-Q (reporting date: 2021-10-29), 10-Q (reporting date: 2021-07-30), 10-K (reporting date: 2021-04-30), 10-Q (reporting date: 2021-01-29), 10-Q (reporting date: 2020-10-30), 10-Q (reporting date: 2020-07-31), 10-K (reporting date: 2020-04-24), 10-Q (reporting date: 2020-01-24), 10-Q (reporting date: 2019-10-25), 10-Q (reporting date: 2019-07-26), 10-K (reporting date: 2019-04-26), 10-Q (reporting date: 2019-01-25), 10-Q (reporting date: 2018-10-26), 10-Q (reporting date: 2018-07-27), 10-K (reporting date: 2018-04-27), 10-Q (reporting date: 2018-01-26), 10-Q (reporting date: 2017-10-27), 10-Q (reporting date: 2017-07-28).

Balance sheet item Description The company
Current liabilities Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. Medtronic PLC current liabilities as a percentage of total liabilities and equity increased from Q1 2024 to Q2 2024 and from Q2 2024 to Q3 2024.
Noncurrent liabilities Amount of obligation due after one year or beyond the normal operating cycle, if longer. Medtronic PLC noncurrent liabilities as a percentage of total liabilities and equity decreased from Q1 2024 to Q2 2024 but then slightly increased from Q2 2024 to Q3 2024.
Total liabilities Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. Medtronic PLC total liabilities as a percentage of total liabilities and equity decreased from Q1 2024 to Q2 2024 but then slightly increased from Q2 2024 to Q3 2024.
Shareholders’ equity Total of all stockholders’ equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity stockholders’ equity attributable to the parent excludes the amount of stockholders’ equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. Medtronic PLC shareholders’ equity as a percentage of total liabilities and equity increased from Q1 2024 to Q2 2024 but then slightly decreased from Q2 2024 to Q3 2024.